Jim Simons's position in Pfizer is currently worth $475 Million. That's 0.63% of their equity portfolio (15th largest holding). The first Pfizer trade was made in Q4 2013. Since then Jim Simons bought shares fourteen more times and sold shares on eighteen occasions. The investor's estimated purchase price is $535 Million, resulting in a loss of 11%.